The challenge of personal genomics in germany

Access through your institution Buy or subscribe To the Editor Much has been written about the potential risks and benefits of commercial direct-to-consumer (DTC) genetic and genomics

testing services. Indeed, in several countries regulatory authorities have paid more attention to DTC companies than many would have expected, given the very small size of the market1. One

claim that has been largely uncontested in the clinical, ethical and regulatory literature on DTC genetic and genomics testing is that the German Genetic Diagnosis Law

(_Gendiagnostikgesetz_; GGDL), which has been in effect since 2010, prohibits genetic testing if it is not ordered by a licensed physician (http://www.phgfoundation.org/news/4562/). Here, we

discuss recent developments in Germany that highlight the need to revisit the way we think about regulation and utility of personal genomics. This is a preview of subscription content,

access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn

more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS

OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Wright, C.F. & Gregory-Jones, S. _Genet. Med._ 12, 594 (2010). Article

  Google Scholar  * Wright, C. & MacArthur, D.G. Direct to consumer genetic testing. in _Molecular Genetics and Personalized Medicine. Molecular and Translational Medicine_ (eds. Best,

D.H. & Swensen, J.J.) 215 (Springer, 2012). Book  Google Scholar  * European Science Foundation (ESF). _Personalised Medicine for the European Citizen_. A Forward Look Report (ESF,

2012). * Topol, E. _The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care_ (Basic Books, 2012). Google Scholar  * Kaphingst, K.A. et al. _Genet.

Med._ 14, 681–687 (2012). Article  Google Scholar  * Bloss, C. et al. _N. Engl. J. Med._ 364, 524–534 (2011). Article  CAS  Google Scholar  * Anonymous. _Lancet_ 379, 386 (2012). * Borry, P.

et al. _Eur. J. Hum. Genet._ 20, 715–721 (2012). Article  Google Scholar  * European Academies Science Advisory Council & the Federation of European Academies of Medicine.

Direct-to-Consumer Genetic Testing for Health-Related Purposes in the European Union: The View from EASAC and FEAM (EASAC policy report 18) (EASAC, 2012).

http://www.easac.eu/home/reports-and-statements/detail-view/article/direct-to-co.html Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * University of Zurich, Institute of

Biomedical Ethics, Zurich, Switzerland Effy Vayena * Department of Social Science, King's College London, Health and Medicine, London, UK Barbara Prainsack Authors * Effy Vayena View

author publications You can also search for this author inPubMed Google Scholar * Barbara Prainsack View author publications You can also search for this author inPubMed Google Scholar

CORRESPONDING AUTHOR Correspondence to Effy Vayena. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing financial interests. RIGHTS AND PERMISSIONS Reprints and

permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Vayena, E., Prainsack, B. The challenge of personal genomics in Germany. _Nat Biotechnol_ 31, 16–17 (2013). https://doi.org/10.1038/nbt.2469

Download citation * Published: 09 January 2013 * Issue Date: January 2013 * DOI: https://doi.org/10.1038/nbt.2469 SHARE THIS ARTICLE Anyone you share the following link with will be able to

read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing

initiative